| scholarly article | Q13442814 |
| P50 | author | Michelle Odden | Q59563589 |
| Michael G Shlipak | Q87224063 | ||
| Peter Bacchetti | Q89655223 | ||
| Stephen Sidney | Q92177544 | ||
| Rebecca Scherzer | Q92747306 | ||
| Carl Grunfeld | Q112658101 | ||
| Lynda Anne Szczech | Q117195004 | ||
| P2860 | cites work | Heroin-associated nephropathy | Q22306016 |
| Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study | Q24654287 | ||
| Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis | Q28216384 | ||
| Cystatin C and the risk of death and cardiovascular events among elderly persons | Q28251528 | ||
| Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease | Q28257707 | ||
| Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration | Q28262985 | ||
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| Nephropathy in patients with type 2 diabetes mellitus | Q33746947 | ||
| The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics | Q35206623 | ||
| Microalbuminuria in HIV infection | Q35293817 | ||
| Preventing chronic kidney disease in special populations | Q36101361 | ||
| Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? | Q36103377 | ||
| Dyslipidemia and the progression of renal disease in chronic renal failure patients | Q36335367 | ||
| CARDIA: study design, recruitment, and some characteristics of the examined subjects | Q39292643 | ||
| Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women | Q39641509 | ||
| Cystatin C and mortality risk in the elderly: the health, aging, and body composition study | Q40375333 | ||
| Predictors of proteinuria and renal failure among women with HIV infection | Q40666978 | ||
| Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass | Q42459142 | ||
| Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy | Q43512126 | ||
| Plasma cystatin C as a marker of renal function in patients with liver cirrhosis. | Q43989086 | ||
| Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis | Q44005159 | ||
| Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome | Q44148482 | ||
| Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort | Q44530878 | ||
| Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients | Q44590700 | ||
| Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals | Q45173417 | ||
| Antiretroviral therapy with tenofovir is associated with mild renal dysfunction | Q45207624 | ||
| The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension | Q46169157 | ||
| Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study | Q46206201 | ||
| Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). | Q46480414 | ||
| Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients | Q46834821 | ||
| Hypertriglyceridemia in the acquired immunodeficiency syndrome | Q46951523 | ||
| Cystatin C: efficacy as screening test for reduced glomerular filtration rate | Q73694233 | ||
| Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System | Q77333340 | ||
| Is there an epidemic of HIV Infection in the US ESRD program? | Q80512690 | ||
| Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America | Q81739951 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| P304 | page(s) | 2213-9 | |
| P577 | publication date | 2007-11-12 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study | |
| P478 | volume | 167 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q34301401 | A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans |
| Q34495570 | A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection |
| Q83233659 | A simple model for predicting incidence of chronic kidney disease in HIV-infected patients |
| Q36191484 | APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV. |
| Q38328699 | Application of gene-editing technologies to HIV-1. |
| Q33692733 | Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons |
| Q39086018 | Association of Kidney Function and Early Kidney Injury With Incident Hypertension in HIV-Infected Women |
| Q34828514 | Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected women |
| Q90281902 | Associations of Urine Biomarkers with Kidney Function Decline in HIV-Infected and Uninfected Men |
| Q35175515 | Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study |
| Q37641171 | Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women |
| Q37574064 | Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women |
| Q35206635 | Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors |
| Q88946324 | Creatinine Versus Cystatin C: Differing Estimates of Renal Function in Hospitalized Veterans Receiving Anticoagulants |
| Q33710907 | Cystatin C at Admission in the Intensive Care Unit Predicts Mortality among Elderly Patients |
| Q35189962 | Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons |
| Q36425231 | Cystatin C-Based Evaluation of Kidney Function of HIV-Infected Children in Benin City, Southern Nigeria |
| Q37313436 | Cystatin C: current position and future prospects |
| Q90669948 | Cystatins in Health and Diseases |
| Q37600838 | Does HIV infection promote early kidney injury in women? |
| Q40478687 | Effect of Probiotic Supplement on Cytokine Levels in HIV-Infected Individuals: A Preliminary Study. |
| Q27009523 | Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients |
| Q42875455 | Estimation of Glomerular Filtration Rate by Using Serum Cystatin C and Serum Creatinine Concentrations in Patients with Human Immunodeficiency Virus |
| Q35925654 | Future challenges for clinical care of an ageing population infected with HIV: a modelling study |
| Q37673157 | Gene therapy targeting HIV entry |
| Q52590505 | Genome editing for the treatment of tumorigenic viral infections and virus-related carcinomas. |
| Q34150710 | HIV Infection, Inflammation, Immunosenescence, and Aging |
| Q34281398 | HIV and proteinuria in an injection drug user population. |
| Q37461438 | HIV and the Kidney |
| Q37051743 | HIV viremia and changes in kidney function |
| Q46119552 | Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults |
| Q41986511 | Higher Levels of CYSTATIN C in HIV/AIDS Patients with Metabolic Syndrome. |
| Q37980388 | How to manage HIV-infected patients with chronic kidney disease in the HAART era. |
| Q37534052 | Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio. |
| Q41454338 | Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity |
| Q28543876 | Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review |
| Q34204026 | Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort |
| Q37386153 | Interruption of antiretroviral therapy is associated with increased plasma cystatin C |
| Q46653347 | Kidney Disease in HIV-Infected Persons |
| Q33925821 | Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula |
| Q54219247 | Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study. |
| Q33857515 | Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection |
| Q36206108 | Markers of renal disease and function are associated with systemic inflammation in HIV infection |
| Q38462651 | Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs |
| Q34158739 | Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz |
| Q27009315 | Proteinuria in paediatric patients with human immunodeficiency virus infection |
| Q34572458 | Recent developments in HIV-related kidney disease |
| Q35000346 | Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM) |
| Q35652795 | Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s |
| Q37154741 | Renal disease in patients with HIV infection: epidemiology, pathogenesis and management |
| Q38031028 | Renal toxicity associated with antiretroviral therapy |
| Q33639802 | Screening for chronic kidney disease in HIV-infected patients |
| Q34254770 | Serum albumin and kidney function decline in HIV-infected women |
| Q41145204 | Serum and urinary cystatin C in cats with feline immunodeficiency virus infection and cats with hyperthyroidism |
| Q35895001 | The Cross-Sectional Association of Energy Intake and Dietary Energy Density with Body Composition of Children in Southwest China |
| Q35060772 | The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study |
| Q38816195 | The clinical implications of HIV infection and aging |
| Q39203030 | The problem of renal function monitoring in patients treated with the novel antiretroviral drugs |
| Q38187385 | The validity of the modification of diet in renal disease formula in HIV-infected patients: a systematic review |
| Q37126287 | Update on cystatin C: incorporation into clinical practice |
| Q26738912 | Urinary Markers of Tubular Injury in HIV-Infected Patients |
| Q37684606 | Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS). |
| Q36431302 | Urinary markers of kidney injury and kidney function decline in HIV-infected women |
| Q33778097 | Use of cystatin C to inform metformin eligibility among adult veterans with diabetes |
| Q40837133 | Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women |
Search more.